日本のドラッグデリバリー市場レポート：投与経路、用途、エンドユーザー、地域別、2025年～2033年

日本のドラッグデリバリー市場の市場規模は2024年に127億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに181億米ドルに達し、2025～2033年の成長率（CAGR）は4％になると予測しています。これらのデバイスの市場は、慢性疾患の有病率の上昇、製薬研究の進歩、新規ドラッグデリバリー技術の継続的開発によって牽引されています。

本レポートで扱う主な質問

• 日本のドラッグデリバリー市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本のドラッグデリバリー市場に与えた影響は？
• 日本のドラッグデリバリー市場の投与経路別の内訳は？
• 日本のドラッグデリバリー市場の用途別の内訳は？
• 日本のドラッグデリバリー市場のエンドユーザー別の内訳は？
• 日本のドラッグデリバリー市場のバリューチェーンにはどのような段階がありますか？
• 日本のドラッグデリバリーデバイスの主な促進要因と課題は？
• 日本のドラッグデリバリー市場の構造と主要プレーヤーは？
• 日本のドラッグデリバリー市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本のドラッグデリバリー市場：イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本のドラッグデリバリー市場情勢

• 過去および現在の市場動向（2019年～2024年）
• 市場予測（2025-2033）

第6章 日本のドラッグデリバリー市場：投与経路別の内訳

• 注射
• 外用
• 眼科
• その他

第7章 日本のドラッグデリバリー市場：用途別の内訳

• がん
• 心臓血管
• 糖尿病
• 感染症
• その他

第8章 日本のドラッグデリバリー市場：エンドユーザー別の内訳

• 病院
• 外来手術センター
• その他

第9章 日本のドラッグデリバリー市場：競合情勢

• 概要
• 市場構造
• 市場プレーヤーのポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本のドラッグデリバリー市場：業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan drug delivery devices market size reached USD 12.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4% during 2025-2033. The market for these devices is driven by the rising prevalence of chronic diseases, advancements in pharmaceutical research, and the continual development of novel drug delivery technologies.

Drug delivery devices constitute a fundamental component of medical equipment designed to administer medications and therapeutic agents across diverse routes in the human body. They are specifically to ensure precise, controlled, and targeted delivery of drugs to achieve optimal therapeutic effect while minimizing side effects. They encompass a variety of forms including, but not limited to, injectors, inhalers, patches, and implantable devices. The evolution of drug delivery devices is crucial in addressing the growing need for innovative solutions to administer medication effectively to treat various diseases and conditions. They also play a pivotal role in transforming therapeutic practices, thereby contributing significantly to the advancement of healthcare solutions.

Japan Drug Delivery Devices Market Trends:

The Japan drug delivery devices market is traversing a phase of substantial growth and transformation, propelled by several pivotal drivers and marked by emerging trends. A primary driver is the escalating prevalence of chronic diseases and aging population in Japan, necessitating advanced therapeutic approaches and effective drug delivery systems. These health conditions demand enhanced medical attention and innovative therapeutic solutions, paving the way for the proliferation of sophisticated drug delivery devices in the country. Japan's strong focus on research and development is another significant catalyst, fostering innovations and advancements in drug delivery technologies. The emphasis on developing patient-centric devices that are more convenient, efficient, and less invasive is driving the trend of personalization and customization in the market. Technological advancements are leading to the emergence of novel drug delivery systems, aiming to optimize therapeutic outcomes and mitigate adverse effects. Moreover, a supportive regulatory environment and substantial investments in healthcare are facilitating the rapid adoption of new technologies and ensuring the safety and efficacy of these devices. The increasing consumer awareness and healthcare literacy are also contributing to the growing demand for advanced drug delivery devices. The convergence of nanotechnology with drug delivery represents a noteworthy trend, offering opportunities for creating devices with enhanced precision and control. In essence, the amalgamation of innovative technologies, burgeoning healthcare needs, and a conducive regulatory landscape is shaping the trajectory of the drug delivery devices market in Japan, highlighting a promising outlook filled with innovations and opportunities.

Japan Drug Delivery Devices Market Segmentation:

Route of Administration Insights:

• Injectable
• Topical
• Ocular
• Others

Application Insights:

• Cancer
• Cardiovascular
• Diabetes
• Infectious diseases
• Others

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan drug delivery devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan drug delivery devices market?
• What is the breakup of the Japan drug delivery devices market on the basis of route of administration?
• What is the breakup of the Japan drug delivery devices market on the basis of application?
• What is the breakup of the Japan drug delivery devices market on the basis of end user?
• What are the various stages in the value chain of the Japan drug delivery devices market?
• What are the key driving factors and challenges in the Japan drug delivery devices?
• What is the structure of the Japan drug delivery devices market and who are the key players?
• What is the degree of competition in the Japan drug delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Delivery Devices Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Drug Delivery Devices Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Drug Delivery Devices Market - Breakup by Route of Administration

• 6.1 Injectable
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Topical
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Ocular
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Others
  • 6.4.1 Historical and Current Market Trends (2019-2024)
  • 6.4.2 Market Forecast (2025-2033)

7 Japan Drug Delivery Devices Market - Breakup by Application

• 7.1 Cancer
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Cardiovascular
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Diabetes
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Infectious Diseases
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Drug Delivery Devices Market - Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Others
  • 8.3.1 Historical and Current Market Trends (2019-2024)
  • 8.3.2 Market Forecast (2025-2033)

9 Japan Drug Delivery Devices Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Drug Delivery Devices Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix